Tatva Chintan Pharma Chem (BOM:543321) Construction In Progress: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543321 Tatva Chintan Pharma Chem Ltd BOM:543321
79 GF Score
Price ₹1,428.45
GF Value ₹1,491.99
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Tatva Chintan Pharma Chem Construction In Progress?

Tatva Chintan Pharma Chem BOM:543321 +0.85% 79 Construction In Progress is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:543321 with a GF Score™ of 79/100 and a GF Value™ of ₹1,491.99 (Fairly Valued). The stock has 6 warning signs investors should review.

Tatva Chintan Pharma Chem's quarterly construction in progress increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹233 Mil) but then declined from Mar. 2026 (₹233 Mil) to Jun. 2026 (₹0 Mil).

Tatva Chintan Pharma Chem's annual construction in progress declined from Mar. 2024 (₹729 Mil) to Mar. 2025 (₹215 Mil) but then increased from Mar. 2025 (₹215 Mil) to Mar. 2026 (₹233 Mil).

Tatva Chintan Pharma Chem Construction In Progress Historical Data

* Premium members only.

The historical data trend for Tatva Chintan Pharma Chem's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tatva Chintan Pharma Chem Construction In Progress Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial 514.91 2,307.44 729.27 215.35 233.48

Tatva Chintan Pharma Chem Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 798.80 0.00 233.48 0.00
BOM:543321
79GF Score
Tatva Chintan Pharma Chem Ltd BOM:543321
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tatva Chintan Pharma Chem Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹0 Mil mean?
Tatva Chintan Pharma Chem (BOM:543321) has a Construction In Progress of ₹0 Mil as of Jun. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Tatva Chintan Pharma Chem and its competitors.
Is Tatva Chintan Pharma Chem's Construction In Progress too high?
Tatva Chintan Pharma Chem's current Construction In Progress is ₹0 Mil. Overall, Tatva Chintan Pharma Chem has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tatva Chintan Pharma Chem's Construction In Progress compare to LIN and SHW?
Tatva Chintan Pharma Chem's Construction In Progress of ₹0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Chemicals company?
A good Construction In Progress depends on the Chemicals industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Tatva Chintan Pharma Chem and its competitors. Tatva Chintan Pharma Chem's current Construction In Progress is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tatva Chintan Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem (BOM:543321) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,491.99, compared to a current price of ₹1,428.45 — trading 4.3% below its estimated fair value. The current Construction In Progress is ₹0 Mil. Tatva Chintan Pharma Chem's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Tatva Chintan Pharma Chem (BOM:543321), the current Construction In Progress is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tatva Chintan Pharma Chem (BOM:543321) Overvalued in 2026?

Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be undervalued. The current stock price of ₹1,428.45 is trading 4.3% below its estimated GF Value™ of ₹1,491.99. GuruFocus considers Tatva Chintan Pharma Chem to be Fairly Valued.

Key valuation signals for BOM:543321:

  • Construction In Progress: ₹0 Mil
  • GF Value™: ₹1,491.99 vs. price of ₹1,428.45 (4.3% below fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the BOM:543321 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tatva Chintan Pharma Chem Business Description

Other Exchanges TATVA:India
Address Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
79GF Score

Get the complete analysis for BOM:543321

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,428.45
Price
₹1,491.99
GF Value